United Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade United Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About UTHR

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. 

CEO
Martine A. Rothblatt
CEOMartine A. Rothblatt
Employees
1,305
Employees1,305
Headquarters
Silver Spring, Maryland
HeadquartersSilver Spring, Maryland
Founded
1996
Founded1996
Employees
1,305
Employees1,305

UTHR Key Statistics

Market cap
13.17B
Market cap13.17B
Price-Earnings ratio
11.87
Price-Earnings ratio11.87
Dividend yield
—
Dividend yield—
Average volume
400.12K
Average volume400.12K
High today
$299.16
High today$299.16
Low today
$290.92
Low today$290.92
Open price
$298.45
Open price$298.45
Volume
300.63K
Volume300.63K
52 Week high
$417.82
52 Week high$417.82
52 Week low
$266.98
52 Week low$266.98

Analyst ratings

71%

of 14 ratings
Buy
71.4%
Hold
28.6%
Sell
0%

People also own

Based on the portfolios of people who own UTHR. This list is generated using Robinhood data, and it’s not a recommendation.
Vertex Pharmaceuticals
Exelixis
Sprouts Farmers Market
VeriSign
Novo Nordisk
Gilead Sciences
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.